eHealth interventions for people with chronic kidney disease 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 181 participants
Low

Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs placebo

Normalcy of diet (mean worst ability to eat, 1 to 4 scale) · Adults with cancer receiving treatment

Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in normalcy of diet (mean worst ability to eat, 1 to 4 scale) compared with placebo; GRADE not reported.

1 finding from 1 review

Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomes
BMT/SCT after conditioning for haematological cancers
MD -0.50 [-1.21, 0.21]
1 study · 42 participants
GRADE not reported

Granulocyte-colony stimulating factor (G-CSF; pegfilgrastim, single dose) vs Granulocyte-colony stimulating factor (G-CSF; filgrastim, multiple doses)

Normalcy of diet (total parenteral nutrition) · Children receiving bone marrow/stem cell transplantation after conditioning therapy for mixed cancers

Granulocyte-colony stimulating factor (G-CSF; pegfilgrastim, single… showed no clear difference in normalcy of diet (total parenteral nutrition) compared with granulocyte-colony stimulating factor (G-CSF; filgrastim, multiple…; GRADE not reported.

1 finding from 1 review

Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomes
Children
RR 1.00 [0.94, 1.06]
1 study · 61 participants
GRADE not reported

Granulocyte-macrophage colony-stimulating factor (GM-CSF), mouthwash vs Sucralfate mouthwash

Normalcy of diet (percutaneous endoscopic gastrostomy) · Adults receiving radiotherapy to the head and neck

Granulocyte-macrophage colony-stimulating factor (GM-CSF), mouthwash showed no clear difference in normalcy of diet (percutaneous endoscopic gastrostomy) compared with sucralfate mouthwash; GRADE not reported.

1 finding from 1 review

Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomes
RT to head and neck
RR 0.18 [0.01, 3.56]
1 study · 40 participants
GRADE not reported

Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs placebo

Normalcy of diet (supplemental nutrition: TPN, PEG, nasogastric tube or IV hydration) · Adults with cancer receiving treatment

Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in normalcy of diet (supplemental nutrition: TPN, PEG, nasogastric tube… compared with placebo; GRADE not reported.

1 finding from 1 review

Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomes
RT to head and neck with cisplatin/fluorouracil
RR 1.03 [0.77, 1.37]
3 studies · 473 participants
GRADE not reported

Intervention not reported

Cost per participant ‐ Doctor dietitian versus standard care · Adults or children with overweight or obesity

1 finding from 1 review

Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction… 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 182 participants
Low

Intervention not reported

Cost per participant ‐ Dietitian versus standard care · Adults or children with overweight or obesity

1 finding from 1 review

Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction… 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 178 participants
Low

Laparoscopic vs open surgery

Postoperative time to liquid diets (days) · patients with sigmoid diverticulitis

1 finding from 1 review

Laparoscopic versus open resection for sigmoid diverticulitis 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 247 participants
Very low

Laparoscopic vs open surgery

Postoperative time to solid diets (days) · patients with sigmoid diverticulitis

1 finding from 1 review

Laparoscopic versus open resection for sigmoid diverticulitis 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 247 participants
Very low

Targeted mass media intervention vs targeted mass media intervention plus personalised content

Intake meeting target from dietary guidelines, 3 months from baseline · adult, ethnic minority groups: Latino immigrants, elderly Chinese immigrants, self‐described Americans of African heritage

It is very uncertain whether targeted mass media intervention changes intake meeting target from dietary guidelines, 3 months from baseline compared with targeted mass media intervention plus personalised content (very low certainty).

1 finding from 1 review

Targeted mass media interventions promoting healthy behaviours to reduce risk of non‐communicable diseases in adult,… 2017 · Cochrane Headline outcomes only
OR 5.53 [1.96, 15.58]
1 study · 718 participants
Very low

Targeted mass media intervention vs targeted mass media intervention plus personalised content

Changes in dietary composition, 12 months from baseline · adult, ethnic minority groups: Latino immigrants, elderly Chinese immigrants, self‐described Americans of African heritage

1 finding from 1 review

Targeted mass media interventions promoting healthy behaviours to reduce risk of non‐communicable diseases in adult,… 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 286 participants
Very low

Targeted mass media intervention vs no intervention

Changes in dietary composition, 12 months from baseline · adult, ethnic minority group: self‐described Americans of African heritage

1 finding from 1 review

Targeted mass media interventions promoting healthy behaviours to reduce risk of non‐communicable diseases in adult,… 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 154 participants
Very low

Alvimopan vs placebo

Time‐to‐tolerance of a solid diet and documented bowel movements

Alvimopan probably leads to higher time‐to‐tolerance of a solid diet and documented bowel movements compared with placebo (moderate certainty).

1 finding from 1 review

Alvimopan for recovery of bowel function after radical cystectomy 2017 · Cochrane Headline outcomes only
HR 1.77 [1.41, 2.23]
1 study · 277 participants
Moderate

GM-CSF vs placebo or no treatment

Normalcy of diet (total parenteral nutrition) · Adults with cancer receiving treatment

Granulocyte-macrophage colony-stimulating factor (GM-CSF) showed no clear difference in normalcy of diet (total parenteral nutrition) compared with placebo or no treatment; GRADE not reported.

1 finding from 1 review

Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomes
BMT/SCT after conditioning for haematological cancers
RR 1.10 [0.63, 1.91]
1 study · 36 participants
GRADE not reported

G‐CSF vs placebo or no treatment

Normalcy of diet (percutaneous endoscopic gastrostomy) · Adults with cancer receiving treatment

Granulocyte-colony stimulating factor (G-CSF) showed no clear difference in normalcy of diet (percutaneous endoscopic gastrostomy) compared with placebo or no treatment; GRADE not reported.

1 finding from 1 review

Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomes
RT to head and neck
RR 0.16 [0.01, 2.86]
1 study · 40 participants
GRADE not reported